Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression

OBJECTIVE: Aldo-keto reductase family 1 member B10 (AKR1B10) is a protein that is produced and secreted by a significant number of breast cancers. However, a potential confounder to the use of AKR1B10 as a tumor marker is its elevation in patients given cytotoxic chemotherapy. We therefore conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Kathy, Cao, Zhe, Delfino, Kristin, Cao, Deliang, Rao, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328017/
https://www.ncbi.nlm.nih.gov/pubmed/37389562
http://dx.doi.org/10.1177/03000605231179317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328017/
https://www.ncbi.nlm.nih.gov/pubmed/37389562
http://dx.doi.org/10.1177/03000605231179317

Ejemplares similares